Epilepsy – BHV7000-304

Participating in a clinical trial with Profound means making a real difference in the lives of others facing similar health challenges.

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of idiopathic generalized epilepsy with generalized tonic-clonic seizures and includes an additional open-label extension (OLE) phase.

Inclusion Criteria:

  • Male and Female participants 18 to 75 years of age at time of consent
  • Diagnosis of Idiopathic Generalized Epilepsy at least 6 months prior to the screening visit
  • Ability of subject or caregiver to keep accurate seizure diaries

Complete the form to get connected with new research studies and our team will reach out soon to help determine your eligibility.

View Study on ClinicalTrials.gov

Trial Interest Form

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
Consent(Required)

Locations

Southern California Neurology Consultants

625 S. Fair Oaks Avenue
Suite 325
Pasadena, California